Calcium, Phosphate, and Magnesium Metabolism and Their Disorders
Normal Physiology
Calcium Metabolism
PTH is the major circulating regulator of calcium homeostasis, acting directly on bone and kidney while indirectly affecting gastrointestinal calcium absorption through vitamin D activation 1. The relationship between serum ionized calcium and PTH secretion follows a steep, negative sigmoidal curve mediated by the calcium-sensing receptor (CaSR) 1. When calcium levels drop, PTH secretion increases rapidly over a very narrow concentration range 1.
PTH maintains calcium homeostasis through three mechanisms:
- Bone: Stimulates calcium release from bone
- Kidney: Enhances calcium reabsorption in renal tubules and promotes phosphate excretion
- Intestine: Indirectly increases calcium absorption by stimulating 1,25-dihydroxyvitamin D production 1
The kidneys play a central role by balancing gastrointestinal absorption with urinary excretion through glomerular filtration and tubular reabsorption 2. Under normal conditions, urinary calcium excretion adjusts to equal net intake 2.
Phosphate Metabolism
Approximately 85% of body phosphorus resides in bone 3. Phosphate homeostasis occurs primarily through renal excretion controlled by PTH and fibroblast growth factor 23 (FGF-23)/Klotho 3. Phosphate is readily absorbed in the gut, enhanced by 1,25-dihydroxyvitamin D 3.
The kidneys regulate phosphate through tubular reabsorption up to a maximum threshold (TmPO4), after which excess phosphate is excreted 4. PTH promotes phosphate excretion (phosphaturic effect), creating an inverse relationship between calcium and phosphate levels 1.
Magnesium Metabolism
Magnesium is a predominantly intracellular cation serving as a cofactor for over 300 phosphate transfer reactions, making it critical for energy metabolism 4. It is essential for both calcium and potassium homeostasis 3. Extracellular magnesium concentrations are largely controlled by the kidneys through tubular maximum reabsorption (TmMg) 4.
Magnesium has a complex relationship with calcium metabolism: severe hypomagnesemia impairs both PTH secretion and action, while hypermagnesemia suppresses PTH, creating functional hypoparathyroidism 1.
Major Disorders
Hypoparathyroidism
When PTH production is absent or deficient, the calcium-conserving effects on renal tubules are lost, along with phosphaturic effects, resulting in characteristic hypocalcemia and hyperphosphatemia 1.
Etiologies (in order of frequency):
- Anterior neck surgery (75% of cases) - most common cause 1
- Autoimmune disease - second most common, affecting parathyroids alone or with other endocrine glands 1
- Magnesium disorders - severe hypomagnesemia impairs PTH secretion/action; hypermagnesemia suppresses PTH 1
- Infiltrative diseases - iron, copper deposits, or tumor metastases destroying parathyroid tissue 1
- Genetic disorders - including activating mutations in CaSR (ADH type 1) or G protein α11 subunit (ADH type 2), DiGeorge syndrome, polyglandular deficiency 1
Clinical manifestations:
- Neuromuscular irritability from hypocalcemia
- Ectopic soft tissue calcification from hyperphosphatemia and elevated calcium-phosphate product (can occur even with normal calcium-phosphate product in chronic hyperphosphatemia) 1
Management approach:
Calcium supplementation: Calcium carbonate (40% elemental calcium) is the mainstay; use calcium citrate (20% elemental calcium) for achlorhydria, proton pump inhibitor therapy, or constipation 1. Doses vary enormously, up to 9 g/day in some patients 1.
Active vitamin D (calcitriol): Rationale is clear since lack of PTH and hyperphosphatemia impair renal conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D. Typical range: 0.25-2 µg daily 1. Titrating upward reduces required calcium supplementation 1.
Parent vitamin D: Supplement with vitamin D2 or D3 for tissue-level production of active metabolites and potential non-skeletal benefits 1.
Monitoring requirements 1:
- Every 3-6 months initially: Calcium, phosphate, magnesium, BUN/creatinine, eGFR
- Yearly once stable: Same parameters
- 24-hour urine calcium: Annually to assess hypercalciuria risk
- Renal imaging: Every 5 years if asymptomatic history of stones; more frequently if symptomatic
- BMD: Standard monitoring per International Society of Clinical Densitometry
Critical pitfall: Disorders of magnesium metabolism can masquerade as hypoparathyroidism - always check magnesium levels 1. Inborn errors of magnesium metabolism present with low calcium and PTH but require magnesium replacement, not calcium 1.
Calcium Supplementation Considerations
Total daily calcium intake should not exceed 1,200-1,500 mg from all sources combined 3. The National Osteoporosis Foundation and American Society for Preventative Cardiology consider calcium intake up to 2,000-2,500 mg/day safe from cardiovascular risk 3. It is most prudent to obtain calcium from food sources and use supplements only to reach recommended intake 3.
Phosphate Disorders
Insufficient phosphate intake leads to impaired bone mineralization, rickets, or osteomalacia, though inadequate intake is rare except in starvation 3. Phosphate is plentiful in most foods, particularly processed foods and sodas 3.
Excessive dietary phosphate increases PTH and FGF-23 levels and bone resorption 3, but does not interfere with calcium absorption if calcium intake is adequate and is not associated with lower BMD 3. Phosphate supplementation in healthy adults is not recommended and may be detrimental to bone, particularly with compromised renal function or low calcium intake 3.
Magnesium's Dual Role in Calcification
Recent evidence reveals magnesium's paradoxical effects: at concentrations up to approximately 5 mM, magnesium stabilizes calcium-phosphate as colloidal protein-mineral particles, paradoxically enhancing calcification by increasing mineral availability; at 10 mM or higher, magnesium completely prevents calcification 5. This demonstrates magnesium's role as both an inhibitor of protein-mineral complex aggregation at high concentrations and a facilitator of mineral availability at moderate concentrations 5.
Genetic Evaluation Triggers
Consider genetic counseling and germline mutation testing when evaluation suggests genetic causes: young age at presentation, family history, candidiasis, or multiple endocrine gland failure 1.